Having demonstrated that PBX3 is upregulated in mesenchymal gliomas and correlated with mesenchymal markers, we wondered whether PBX3 is required for maintenance of mesenchymal phenotype of GBM cells. The gene discussed is PBX3; the disease is central nervous system cancer.